<--- Back to Details
First PageDocument Content
Clinical research / Pharmaceutical industry / Design of experiments / Medical ethics / Institutional review board / Clinical trial / Pharmacovigilance / Office for Human Research Protections / Adverse event / Human subject research / Serious adverse event / Adverse effect
Date: 2014-09-14 03:12:34
Clinical research
Pharmaceutical industry
Design of experiments
Medical ethics
Institutional review board
Clinical trial
Pharmacovigilance
Office for Human Research Protections
Adverse event
Human subject research
Serious adverse event
Adverse effect

Microsoft Word - Unanticipated_Problems

Add to Reading List

Source URL: www.firstclinical.com

Download Document from Source Website

File Size: 36,74 KB

Share Document on Facebook

Similar Documents

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

DocID: 1vrwY - View Document

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

DocID: 1vpIt - View Document

Clinical Research Registration at Public Registry

DocID: 1vnxr - View Document

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

DocID: 1vi9N - View Document

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

DocID: 1vglz - View Document